\-\ Texto\\:\\ \ \(0\)\
\-\ normal\ \(4026\)\
\-\ none\ \(204\)\
\-\ large\\ mass\\ within\\ the\\ medial\\ left\\ lobe\\ of\\ the\\ liver\\ superiorly\\.\\ \\ arterial\\ phase\\ imaging\\ demonstrates\\ a\\ hypoattenuating\\ mass\\ with\\ peripheral\\ nodular\\ enhancement\\ that\\,\\ on\\ subsequent\\ delayed\\ sequences\\ demonstrates\\ centripetal\\ fill\\ in\\ of\\ contrast\\.\\ \\ of\\ note\\,\\ on\\ all\\ sequences\\,\\ the\\ enhancing\\ component\\ of\\ the\\ mass\\ follows\\ the\\ aortic\\ level\\ of\\ enhancement\\.\ \(0\)\
\-\ liver\\ cavernous\\ hemangioma\ \(0\)\
\-\ hepatic\\ hemangioma\ \(3\)\
\-\ focal\\ nodular\\ hyperplasia\ \(9\)\
\-\ adenoma\ \(519\)\
\-\ hepatocellular\\ carcinoma\ \(28\)\
\-\ metatastatic\\ disease\ \(0\)\
\-\ woman\\ evaluated\\ for\\ right\\ upper\\ quadrant\\ pain\\.\ \(0\)\
\-\ this\\ was\\ incidental\\ \\(as\\ is\\ often\\ the\\ case\\)\\.\\ the\\ patient\\'s\\ symptoms\\ resolved\\ without\\ treatment\\ of\\ the\\ hemangioma\\.\\ \\ key\\ to\\ differentiation\\ of\\ this\\ mass\\ from\\ other\\ general\\ liver\\ masses\\ as\\ listed\\ in\\ the\\ differential\\ diagnosis\\ is\\ the\\ characteristic\\ enhancement\\ pattern\\,\\ with\\ complete\\ fill\\ in\\ and\\ persistent\\ enhancement\\ evident\\ on\\ 10\\ minute\\ delay\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hemangioma\\:\\ 0\\.08361254343508868\ \(0\)\
\-\ fill\\:\\ 0\\.08170281166566858\ \(0\)\
\-\ enhancement\\:\\ 0\\.06687558441235142\ \(0\)\
\-\ liver\\:\\ 0\\.06451579950728592\ \(0\)\
\-\ metatastatic\\:\\ 0\\.06434684980997443\ \(0\)\
\-\ nodular\\:\\ 0\\.052327150468787026\ \(0\)\
\-\ sequences\\:\\ 0\\.05209480805556222\ \(0\)\
\-\ centripetal\\:\\ 0\\.051268313538236805\ \(0\)\
\-\ hypoattenuating\\:\\ 0\\.04212405829374507\ \(0\)\
\-\ minute\\:\\ 0\\.04146003071560108\ \(0\)\
\-\ listed\\:\\ 0\\.04085140583283429\ \(0\)\
\-\ key\\:\\ 0\\.03672502766458567\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.03593940237851001\ \(0\)\
\-\ superiorly\\:\\ 0\\.03470857966000058\ \(0\)\
\-\ mass\\:\\ 0\\.03469959144372451\ \(0\)\
\-\ follows\\:\\ 0\\.033547523494820375\ \(0\)\
\-\ differentiation\\:\\ 0\\.03323239815273856\ \(0\)\
\-\ delay\\:\\ 0\\.030954798871993542\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.03073246889035333\ \(0\)\
\-\ resolved\\:\\ 0\\.030238610142369282\ \(0\)\
\-\ phase\\:\\ 0\\.02934107940415881\ \(0\)\
\-\ cavernous\\:\\ 0\\.028930570511291102\ \(0\)\
\-\ evaluated\\:\\ 0\\.028596194335880194\ \(0\)\
\-\ evident\\:\\ 0\\.02854192441991291\ \(0\)\
\-\ component\\:\\ 0\\.0284880550235799\ \(0\)\
\-\ arterial\\:\\ 0\\.02730178546520198\ \(0\)\
\-\ demonstrates\\:\\ 0\\.02724994454968155\ \(0\)\
\-\ characteristic\\:\\ 0\\.026401616005114398\ \(0\)\
\-\ general\\:\\ 0\\.026281625301879653\ \(0\)\
\-\ hepatic\\:\\ 0\\.02604740402778111\ \(0\)\
\-\ adenoma\\:\\ 0\\.02604740402778111\ \(0\)\
\-\ delayed\\:\\ 0\\.02538671784135168\ \(0\)\
\-\ aortic\\:\\ 0\\.025247679921857558\ \(0\)\
\-\ persistent\\:\\ 0\\.024878442719024667\ \(0\)\
\-\ subsequent\\:\\ 0\\.02428161093291833\ \(0\)\
\-\ note\\:\\ 0\\.024073471003662705\ \(0\)\
\-\ pattern\\:\\ 0\\.023842644810739257\ \(0\)\
\-\ incidental\\:\\ 0\\.023618894875768435\ \(0\)\
\-\ peripheral\\:\\ 0\\.022568856365066548\ \(0\)\
\-\ quadrant\\:\\ 0\\.02195164915318288\ \(0\)\
\-\ complete\\:\\ 0\\.02195164915318288\ \(0\)\
\-\ masses\\:\\ 0\\.02108461604376706\ \(0\)\
\-\ 10\\:\\ 0\\.021026454221510293\ \(0\)\
\-\ medial\\:\\ 0\\.019951091340073373\ \(0\)\
\-\ often\\:\\ 0\\.01990126677751571\ \(0\)\
\-\ differential\\:\\ 0\\.019802626491627222\ \(0\)\
\-\ enhancing\\:\\ 0\\.019561704619596783\ \(0\)\
\-\ as\\:\\ 0\\.018869744611593107\ \(0\)\
\-\ level\\:\\ 0\\.017977292172605342\ \(0\)\
\-\ focal\\:\\ 0\\.01781382192801753\ \(0\)\
\-\ carcinoma\\:\\ 0\\.017678304160699754\ \(0\)\
\-\ all\\:\\ 0\\.01764177729511891\ \(0\)\
\-\ lobe\\:\\ 0\\.01678339670017178\ \(0\)\
\-\ on\\:\\ 0\\.015851628008002074\ \(0\)\
\-\ symptoms\\:\\ 0\\.01554494508684773\ \(0\)\
\-\ none\\:\\ 0\\.015472405159912456\ \(0\)\
\-\ upper\\:\\ 0\\.015051682520939549\ \(0\)\
\-\ without\\:\\ 0\\.014686227491665402\ \(0\)\
\-\ imaging\\:\\ 0\\.014613677550770822\ \(0\)\
\-\ woman\\:\\ 0\\.014408050711597856\ \(0\)\
\-\ other\\:\\ 0\\.014376923713156558\ \(0\)\
\-\ diagnosis\\:\\ 0\\.014322768837813284\ \(0\)\
\-\ this\\:\\ 0\\.014031200194366905\ \(0\)\
\-\ contrast\\:\\ 0\\.013961866327065002\ \(0\)\
\-\ \\'s\\:\\ 0\\.013752165097569671\ \(0\)\
\-\ case\\:\\ 0\\.01364601775815526\ \(0\)\
\-\ large\\:\\ 0\\.013638995852781603\ \(0\)\
\-\ treatment\\:\\ 0\\.012624941310955378\ \(0\)\
\-\ within\\:\\ 0\\.011898769404277967\ \(0\)\
\-\ that\\:\\ 0\\.010773581960283381\ \(0\)\
\-\ disease\\:\\ 0\\.010195164534421198\ \(0\)\
\-\ the\\:\\ 0\\.010091188664498232\ \(0\)\
\-\ normal\\:\\ 0\\.009778193099263512\ \(0\)\
\-\ from\\:\\ 0\\.00924405630039571\ \(0\)\
\-\ in\\:\\ 0\\.009227676572414342\ \(0\)\
\-\ is\\:\\ 0\\.008208624501966797\ \(0\)\
\-\ \\,\\:\\ 0\\.007903943518752916\ \(0\)\
\-\ pain\\:\\ 0\\.0076175778651878445\ \(0\)\
\-\ was\\:\\ 0\\.007213704541705743\ \(0\)\
\-\ left\\:\\ 0\\.006978870578634414\ \(0\)\
\-\ right\\:\\ 0\\.006581253351170924\ \(0\)\
\-\ patient\\:\\ 0\\.006252495846105021\ \(0\)\
\-\ of\\:\\ 0\\.00595274894588262\ \(0\)\
\-\ for\\:\\ 0\\.005321957289362884\ \(0\)\
\-\ \\(\\:\\ 0\\.005272713330247157\ \(0\)\
\-\ \\)\\:\\ 0\\.005208304321994928\ \(0\)\
\-\ to\\:\\ 0\\.0031172854630874907\ \(0\)\
\-\ a\\:\\ 0\\.002894889064369352\ \(0\)\
\-\ \\.\\:\\ 0\\.0018138449100833863\ \(0\)\
\-\ with\\:\\ 0\\.0017080901618962004\ \(0\)\
\-\ and\\:\\ 0\\.0013139343484103536\ \(0\)\
